ArticleCell reports. Medicine2022

Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide.

Hannah J Irvine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.